Deciphering the molecular details of interactions between anti-COVID drugs and functional human proteins: in silico approach

被引:3
作者
Trusova, Valeriya M. [1 ]
Zhytniakivska, Olga A. [1 ]
Tarabara, Uliana K. [1 ]
Vus, Kateryna A. [1 ]
Gorbenko, Galyna P. [1 ]
机构
[1] Kharkov Natl Univ, Dept Med Phys & Biomed Nanotechnol, Kharkiv, Ukraine
关键词
SARS-CoV-2; infection; Anti-COVID drugs; Functional proteins; Molecular docking; HUMAN SERUM-ALBUMIN; BINDING-SITES; LYSOZYME; DISCOVERY; QUALITY;
D O I
10.1016/j.jpba.2023.115448
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The molecular docking calculations have been employed to investigate the interactions a set of proteins with the repurposed anti-COVID drugs. The position of the therapeutic agents within the protein structure was dependent on a particular drug-protein system and varied from the binding cleft to the periphery of the polypeptide chain. Interactions involved in the drug-protein complexation includes predominantly hydrogen bonding and hydro-phobic contacts. The obtained results may be of particular importance while developing the anti-COVID stra-tegies as well as for deeper understanding of the drug pharmacodynamics and pharmacokinetics.
引用
收藏
页数:12
相关论文
共 60 条
  • [1] Fasting Blood Glucose and COVID-19 Severity: Nonlinearity Matters
    Alahmad, Barrak
    Al-Shammari, Abdullah A.
    Bennakhi, Abdullah
    Al-Mulla, Fahd
    Ali, Hamad
    [J]. DIABETES CARE, 2020, 43 (12) : 3113 - 3116
  • [2] Toward the estimation of the absolute quality of individual protein structure models
    Benkert, Pascal
    Biasini, Marco
    Schwede, Torsten
    [J]. BIOINFORMATICS, 2011, 27 (03) : 343 - 350
  • [3] Development and evaluation of inhalable composite niclosamide-lysozyme particles: A broad-spectrum, patient-adaptable treatment for coronavirus infections and sequalae
    Brunaugh, Ashlee D.
    Seo, Hyojong
    Warnken, Zachary
    Ding, Li
    Seo, Sang Heui
    Smyth, Hugh D. C.
    [J]. PLOS ONE, 2021, 16 (02):
  • [4] The Drug Repurposing for COVID-19 Clinical Trials Provide Very Effective Therapeutic Combinations: Lessons Learned From Major Clinical Studies
    Chakraborty, Chiranjib
    Sharma, Ashish Ranjan
    Bhattacharya, Manojit
    Agoramoorthy, Govindasamy
    Lee, Sang-Soo
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [5] SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules
    Daina, Antoine
    Michielin, Olivier
    Zoete, Vincent
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [6] A BOILED-Egg To Predict Gastrointestinal Absorption and Brain Penetration of Small Molecules
    Daina, Antoine
    Zoete, Vincent
    [J]. CHEMMEDCHEM, 2016, 11 (11) : 1117 - 1121
  • [7] Drug discovery beyond the rule of 5-Opportunities and challenges
    Doak, Bradley C.
    Kihlberg, Jan
    [J]. EXPERT OPINION ON DRUG DISCOVERY, 2017, 12 (02) : 115 - 119
  • [8] The three recombinant domains of human serum albumin -: Structural characterization and ligand binding properties
    Dockal, M
    Carter, DC
    Rüker, F
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (41) : 29303 - 29310
  • [9] Cytochrome c as a Potentially Clinical Useful Marker of Mitochondria and Cellular Damage
    Eleftheriadis, Theodoros
    Pissas, Georgios
    Liakopoulos, Vassilios
    Stefanidis, Ioannis
    [J]. FRONTIERS IN IMMUNOLOGY, 2016, 7
  • [10] Insights on 3D Structures of Potential Drug-Targeting Proteins of SARS-CoV-2: Application of Cavity Search and Molecular Docking
    Fernandes, Mariana S.
    da Silva, Francielly S.
    Freitas, Ana Carolina S. G.
    de Melo, Eduardo B.
    Trossini, Gustavo H. G.
    Paula, Favero R.
    [J]. MOLECULAR INFORMATICS, 2021, 40 (02)